Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit weight-loss drugs didn’t slow the progress of Alzheimer’s disease. Novo …
Novo Nordisk Stock Price Falls After Ozempic Fails to Slow Alzheimer’s
view original post